Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Intermediate follow-up results from the multicenter engager European pivotal trial.

Holzhey D, Linke A, Treede H, Baldus S, Bleiziffer S, Wagner A, Börgermann J, Scholtz W, Vanoverschelde JL, Falk V.

Ann Thorac Surg. 2013 Dec;96(6):2095-100. doi: 10.1016/j.athoracsur.2013.06.089. Epub 2013 Sep 7.

PMID:
24021766
2.

Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study.

Treede H, Mohr FW, Baldus S, Rastan A, Ensminger S, Arnold M, Kempfert J, Figulla HR.

Eur J Cardiothorac Surg. 2012 Jun;41(6):e131-8. doi: 10.1093/ejcts/ezs129. Epub 2012 Apr 16.

PMID:
22508111
3.

Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation.

Seiffert M, Bader R, Kappert U, Rastan A, Krapf S, Bleiziffer S, Hofmann S, Arnold M, Kallenbach K, Conradi L, Schlingloff F, Wilbring M, Schäfer U, Diemert P, Treede H.

JACC Cardiovasc Interv. 2014 Oct;7(10):1168-74. doi: 10.1016/j.jcin.2014.05.014. Epub 2014 Aug 13.

4.

Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.

Ihlberg L, Nissen H, Nielsen NE, Rück A, Busund R, Klaarborg KE, Soendergaard L, Harnek J, Miettinen H, Eskola M, Wahba A, Laine M.

J Thorac Cardiovasc Surg. 2013 Nov;146(5):1047-54; discussion 1054. doi: 10.1016/j.jtcvs.2013.06.045. Epub 2013 Aug 30.

5.

Outcome of patients treated with Engager transapical aortic valve implantation: one-year results of the feasibility study.

Sündermann SH, Grünenfelder J, Corti R, Rastan AJ, Linke A, Lange R, Falk V, Bleiziffer S.

Innovations (Phila). 2013 Sep-Oct;8(5):332-6. doi: 10.1097/IMI.0000000000000018.

PMID:
24346580
6.

Medium term outcomes of transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation.

D'Onofrio A, Salizzoni S, Agrifoglio M, Cota L, Luzi G, Tartara PM, Cresce GD, Aiello M, Savini C, Cassese M, Cerillo A, Punta G, Cioni M, Gabbieri D, Zanchettin C, Agostinelli A, Mazzaro E, Di Gregorio O, Gatti G, Faggian G, Filippini C, Rinaldi M, Gerosa G.

Ann Thorac Surg. 2013 Sep;96(3):830-5; discussion 836. doi: 10.1016/j.athoracsur.2013.04.094. Epub 2013 Jul 16.

PMID:
23870695
7.

Transapical aortic valve implantation in patients with previous cardiac surgery.

Papadopoulos N, Ilioska P, Fichtlscherer S, Lehmann R, Beiras Fernandez A, Moritz A, Doss M, Zierer A.

Ann Thorac Surg. 2014 Jan;97(1):37-42. doi: 10.1016/j.athoracsur.2013.07.077. Epub 2013 Sep 24.

PMID:
24075497
8.

Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response.

Gotzmann M, Pljakic A, Bojara W, Lindstaedt M, Ewers A, Germing A, Mügge A.

Am Heart J. 2011 Aug;162(2):238-245.e1. doi: 10.1016/j.ahj.2011.05.011. Epub 2011 Jul 18.

PMID:
21835283
9.

Transcatheter aortic valve implantation by the left axillary approach: a single-center experience.

Laflamme M, Mazine A, Demers P, Lamarche Y, Ibrahim R, Asgar A, Cartier R.

Ann Thorac Surg. 2014 May;97(5):1549-54. doi: 10.1016/j.athoracsur.2013.11.019. Epub 2014 Jan 24.

PMID:
24462415
10.

Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.

Schlingloff F, Schäfer U, Frerker C, Schmoeckel M, Bader R.

Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):388-93. doi: 10.1093/icvts/ivu155. Epub 2014 Jun 3.

PMID:
24893871
11.

Transapical transcatheter aortic valve implantation using a new second-generation TAVI system - J-Valve™ for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up.

Zhu D, Chen Y, Guo Y, Hu J, Zhang J, Wei X, Tang H, Shi Y.

Int J Cardiol. 2015 Nov 15;199:155-62. doi: 10.1016/j.ijcard.2015.07.037. Epub 2015 Jul 12.

PMID:
26197402
12.

Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis.

Gotzmann M, Lindstaedt M, Bojara W, Ewers A, Mügge A.

Catheter Cardiovasc Interv. 2012 Apr 1;79(5):693-701. doi: 10.1002/ccd.23240. Epub 2011 Aug 5.

PMID:
21805576
13.

Transapical transcatheter aortic valve implantation: follow-up to 3 years.

Ye J, Cheung A, Lichtenstein SV, Nietlispach F, Albugami S, Masson JB, Thompson CR, Munt B, Moss R, Carere RG, Jamieson WR, Webb JG.

J Thorac Cardiovasc Surg. 2010 May;139(5):1107-13, 1113.e1. doi: 10.1016/j.jtcvs.2009.10.056.

14.

The transapical approach for aortic valve implantation.

Zierer A, Wimmer-Greinecker G, Martens S, Moritz A, Doss M.

J Thorac Cardiovasc Surg. 2008 Oct;136(4):948-53. doi: 10.1016/j.jtcvs.2008.06.028.

15.

Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.

Onorati F, D'Errigo P, Grossi C, Barbanti M, Ranucci M, Covello DR, Rosato S, Maraschini A, Santoro G, Tamburino C, Seccareccia F, Santini F, Menicanti L; OBSERVANT Research Group..

J Thorac Cardiovasc Surg. 2014 Feb;147(2):568-75. doi: 10.1016/j.jtcvs.2013.10.006. Epub 2013 Nov 19.

16.

Clinical outcome following Transcatheter Aortic Valve Implantation in patients with impaired left ventricular systolic function.

van der Boon RM, Nuis RJ, Van Mieghem NM, Benitez LM, van Geuns RJ, Galema TW, van Domburg RT, Geleijnse ML, Dager A, de Jaegere PP.

Catheter Cardiovasc Interv. 2012 Apr 1;79(5):702-10. doi: 10.1002/ccd.23423. Epub 2012 Jan 10.

PMID:
22121094
17.

Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.

Lefèvre T, Colombo A, Tchétché D, Latib A, Klugmann S, Fajadet J, De Marco F, Maisano F, Bruschi G, Bijuklic K, Nava S, Weissman N, Low R, Thomas M, Young C, Redwood S, Mullen M, Yap J, Grube E, Nickenig G, Sinning JM, Hauptmann KE, Friedrich I, Lauterbach M, Schmoeckel M, Davidson C, Schofer J.

JACC Cardiovasc Interv. 2016 Jan 11;9(1):68-75. doi: 10.1016/j.jcin.2015.09.027.

18.

Transcatheter valve-in-valve implantation for deteriorated aortic bioprosthesis: initial clinical results and follow-up in a series of high-risk patients.

Wilbring M, Sill B, Tugtekin SM, Alexiou K, Simonis G, Matschke K, Kappert U.

Ann Thorac Surg. 2012 Mar;93(3):734-41. doi: 10.1016/j.athoracsur.2011.11.008. Epub 2012 Feb 3.

PMID:
22304904
19.

[Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement].

Zahn R, Schiele R, Kilkowski C, Klein B, Schwarz AK, Zeymer U, Lehmann A, Cornelius B, Horack M, Saggau W, Werling C.

Dtsch Med Wochenschr. 2010 Aug;135(33):1589-95. doi: 10.1055/s-0030-1262450. Epub 2010 Aug 17. German.

PMID:
20717862
20.

1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.

Meredith IT, Walters DL, Dumonteil N, Worthley SG, Tchétché D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Feldman TE, Allocco DJ, Dawkins KD.

JACC Cardiovasc Interv. 2016 Feb 22;9(4):376-84. doi: 10.1016/j.jcin.2015.10.024.

Supplemental Content

Support Center